Healthcare Hero: Kara Cossis, Chesapeake Urology April 12, 2023 At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a... Continue Reading
Medical Experts Discuss Benefits of Genetic Testing in Prostate Cancer Care March 23, 2023 In a recent Myriad Live webinar, our Chief Medical Officer, Thomas Slavin, hosted a lively conversation about prostate cancer with two experts from the field: ... Continue Reading
Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing January 13, 2023 https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa... Continue Reading
Can a genetic test improve prostate cancer treatment decisions? A patient story. October 25, 2022 https://myriad-1.wistia.com/medias/w9go8af7h5 How can a prognostic test inform care plans for a patient with prostate cancer? Richard Tyus and his uro... Continue Reading
Myriad Genetics is committed to being your partner of choice August 5, 2022 Against the backdrop of recent shifts in the genetic testing industry, we would like to take a minute to reiterate Myriad Genetics’ determination to bring cl... Continue Reading
Understanding Prolaris test results June 17, 2022 After a prostate cancer diagnosis, choosing an appropriate treatment path can be incredibly stressful for you and your loved ones. Further complicating the pro... Continue Reading
What is the Prolaris test? June 10, 2022 The Prolaris test is a genetic test for untreated men with prostate cancer that can determine how quickly cancer is growing. Prolaris helps provide clarity abo... Continue Reading
Genetic insights for more actionable and personalized prostate cancer March 25, 2022 Connect with us The AUA National meeting is centered around the exploration of the latest and groundbreaking advancements in urology, and th... Continue Reading
1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation September 17, 2020 Knowing the status of your patient’s BRCA 1/2 germline status is critical. Myriad hereditary cancer tests give you definitive and actionable risk stratificat... Continue Reading
Genetic Testing Changed My Life September 4, 2020 After a visit with his family doctor, John Earp had a PSA of 13.96. With this new possible diagnosis of prostate cancer, he began to worry thinking about his e... Continue Reading
The Importance of a Prolaris Score August 17, 2017 How Your Prolaris Score Can Help Determine Your Treatment Plan Prostate cancer is a common diagnosis among men. Fortunately, the Prolaris test c... Continue Reading